Noven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
Noven Pharmaceuticals is recalling Minivelle (estradiol) transdermal systems because the adhesive may not meet specifications, causing patches to stick poorly to the skin.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a functional defect (adhesive failure) rather than a toxicological or structural safety risk, fitting the Moderate criteria for low-risk issues.
Plain-English summary
Noven Pharmaceuticals, Inc. is recalling 61,960 boxes of Minivelle (estradiol transdermal system) 0.1 mg/day. The affected products are identified by Lot # 81391 and 81638, with an expiration date of 10/18. The recall covers products distributed nationwide in the USA.
The recall was initiated because the delivery system no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Consumers should check their Minivelle products for the specific lot numbers listed above. If the product matches the recalled lots, patients should stop using the patches and contact their healthcare provider or pharmacist for guidance on alternative treatment options.
The recalled product
- Product
- MINIVELLE (ESTRADIOL)
- Brand
- MINIVELLE
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Category
- Drug — Transdermal Patch
- Affected units
- 61,960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 81391
- 81638 Exp. 10/18
UPCs (1)
- 0368968665083
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Noven Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · MINIVELLE
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- SevereNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
Same manufacturer · Noven Pharmaceuticals, Inc.
See all →- HighPrescription Dextroamphetamine Patches Recalled for Defective Adhesive System
FDA (Drugs) · 2024-11-27
- HighDaytrana methylphenidate patches recalled for defective delivery system
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Patches Recalled for Defective Transdermal Delivery System
FDA (Drugs) · 2023-03-29
- ModerateDaytrana Methylphenidate Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
Same hazard · adhesive failure
See all →- SevereGrand Design Lineage solar panels may detach from the roof
NHTSA · 2026-04-30
- ModerateArrowgard Blue MAC Central Venous Access Kit recalled for defective adhesive
FDA (Devices) · 2026-04-29
- HighArrow Percutaneous Sheath Introducer Catheter Recall Due to Adhesive Defect
FDA (Devices) · 2026-04-29
- ModerateArrow Pressure Injectable Central Venous Catheters Recalled
FDA (Devices) · 2026-04-29
- Severe